Intel has announced a $15bn common-stock offering, a sale that could swell to as much as $20bn if underwriters take up their overallotment options.

It is a bold move for a company that, not long ago, looked like a cautionary tale, and it shows just how far the chipmaker’s fortunes have turned in the space of a year.

The timing is no accident. Intel shares have nearly tripled in 2026, outrunning AMD, Nvidia and the Philadelphia Semiconductor Index, which is up roughly 75% over the same stretch.

When your stock is running that hot, issuing new shares is one of the cheapest ways to raise money, and Intel is plainly striking while the iron is warm.

The offering was priced at around $95 a share or higher, a modest discount of about 2.6% to Monday’s close of $97.52.

That is a slim concession by the standards of large equity raises, and it reflects the appetite investors have shown for a name many had written off during the darkest days of its restructuring.

The proceeds are earmarked for the part of the business that matters most to Intel’s comeback.

The money will fund its foundry arm, paying for new manufacturing facilities and advanced packaging as the company tries to compete with TSMC in contract chipmaking, the fiercely capital-hungry business of building chips for other companies.

That ambition has grown more expensive as demand has surged. AI-driven processor orders have pushed beyond Intel’s current capacity, prompting it to lift its 2026 capital-spending forecast from $18bn to $20bn, and to commit to production on its cutting-edge 14A process by 2028. Fresh equity helps bankroll those promises without piling on debt.

There is genuine momentum behind the pitch, too. Intel has named Tesla as a customer for its 14A process, and reports point to a potential partnership with Apple, either of which would lend credibility to a foundry that has long struggled to win marquee clients away from the Taiwanese incumbent.

Investors, for their part, could hardly get enough. Demand for the offering reportedly exceeded $100bn, a staggering figure that speaks to how thoroughly sentiment has shifted. One analyst put the logic plainly, arguing that raising money “makes perfect sense” after a roughly five-fold rise in the stock since last August.

None of this came from nowhere. The turnaround has been underwritten in part by the US government’s stake in Intel and by a string of high-profile investments, alongside strategic moves such as joining Musk’s Terafab as a foundry partner and committing billions to production in Ireland.

Yet the market’s reaction on the day was a useful reality check. Intel shares fell about 4 to 5% when the sale was announced, a dip that reflects dilution rather than any loss of faith.

More shares outstanding means each existing holder owns a slightly smaller slice of the company, and the stock price adjusts accordingly.

The deeper question is whether the foundry bet pays off at all. Catching TSMC is a formidable undertaking, one that has humbled Intel before, and the 14A roadmap remains unproven at the volumes and yields that would make it commercially viable.

Landing Tesla and courting Apple are encouraging signs, but they are not the same as sustained, profitable contract manufacturing.

Intel has also been building out the products that sit atop that manufacturing, from its 18A process and new chips to the packaging technologies it hopes will differentiate it.

The share sale buys time and capacity for all of it, though execution, not cash, is the variable that will ultimately decide the story.

For now, Intel is doing exactly what a recovering company should do when the window is open. It is converting a remarkable rally into the funding it needs for its most important, and most uncertain, wager, and betting that the goodwill will hold long enough to prove the doubters wrong.

Get the TNW newsletter

Get the most important tech news in your inbox each week.